IRON
IRON
NASDAQ · Biotechnology

Disc Medicine Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$68.26
+0.73 (+1.08%)
As of May 9, 1:25 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -67.1% upside
Low Target $15.33
Average Target $22.47
High Target $35.88
Current Price $68.26
Current
$68.26
Target
$22.47
$15.33 $22.47 avg $35.88
Scenario Analysis
Bear Case
$15.33
-77.5%
Low target
Base Case
$22.47
-67.1%
Avg target
Bull Case
$35.88
+-47.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$99.50
-31.4% from high
52-Week Low
$40.00
+70.6% from low
50-Day SMA
$78.91
-13.5% vs SMA
200-Day SMA
$68.08
+0.3% vs SMA
RSI (14)
34.9
Neutral
Target vs 52W High
$22.47
-77.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%